← All cohorts · COVID-19 vaccine (mRNA / spike-based) cohorts

Post-Vac-Syndrom Deutschland patient survey

source record (JSON) · schema v2.0.0 · CC BY 4.0

Flags: grey literature not peer-reviewed patient-reported self-selected no control unverified source — read the observations and design fields with these caveats in mind.
Design notes & limitations. Grey-literature patient-organisation survey (n=777, Feb-Jun 2022) of people reporting post-vaccination symptoms in Germany. Not peer-reviewed and with no DOI/PMID, so it is admitted only as a flagged grey-literature source (allowed by a URL-only publication record) to represent the patient-advocacy end of the spectrum honestly. Most figures are subgroup percentages (e.g. among affected women); onset was within one week in 57% and within two weeks in a further 21%. Prevalence figures cannot be interpreted as population estimates.

Identity & trigger

Cohort id
postvac-germany-survey
Aliases
PVS Deutschland Umfrage
Outbreak / event
COVID-19 vaccination campaign (2021-)
Pathogen
COVID-19 vaccine (mRNA / spike-based) (Vaccine)
Exposure ascertainment
self report

Design

Design
Survey
Denominator defined
No
Denominator method
n/r
Recruitment
patient organisation
Time zero
COVID-19 vaccination; self-reported post-vaccination symptoms (week)
Control group
None

Size & attrition

Enrolled
777
Analysed / enrolled
777/777 (100%)
Max follow-up (months)
6

Biospecimens

Specimens
No
Types
none
Acute-phase specimens
N/A
Biobank
N/A
External access
open application

Observations (1)

Symptoms

57% Proportion

Measure
Paraesthesia / numbness sym:paresthesia
As worded
“tingling / numbness sensations (most common symptom; reported by women)”
Population
subgroup · denominator Symptomatic subset · N=measured, not reported
Timing
6 mo (3-6 mo) · ref Current
Method
Open-ended report
Comparator
no comparator
Comparability signature
66e703339c — measure sym:paresthesia · Open-ended report · ref Current · denom Symptomatic subset · 3-6 mo · Proportion
Provenance
Survey results page (tingling/numbness 57% of women) · Manual · verified OSMF research-tracker on 2026-07-20

Publications

Provenance & verification

Registration
n/r
Funders
Post-Vac-Syndrom Deutschland (patient initiative)
Related cohorts
vitae-survey (Sibling analysis), yale-listen-pvs (Sibling analysis)
Symptom-inventory scope
Targeted panel
Last verified
2026-07-20 — OSMF research-tracker (verified against source webpage)